When.com Web Search

  1. Ads

    related to: proin 50 mg chewable tablets side effect for dogs reviews

Search results

  1. Results From The WOW.Com Content Network
  2. Phenylpropanolamine - Wikipedia

    en.wikipedia.org/wiki/Phenylpropanolamine

    In June 2024, the US Food and Drug Administration (FDA) approved Phenylpropanolamine Hydrochloride chewable tablets for the control of urinary incontinence due to a weakening of the muscles that control urination (urethral sphincter hypotonus) in dogs. [78] [79] [80] This is the first generic phenylpropanolamine hydrochloride chewable tablets ...

  3. Maropitant - Wikipedia

    en.wikipedia.org/wiki/Maropitant

    Side effects in dogs and cats include hypersalivation, diarrhea, loss of appetite, and vomiting. [12] [16] Eight percent of dogs taking maropitant at doses meant to prevent motion sickness vomited right after, likely due to the local effects maropitant had on the gastrointestinal tract. Small amounts of food beforehand can prevent such post ...

  4. Sucroferric oxyhydroxide - Wikipedia

    en.wikipedia.org/wiki/Sucroferric_oxyhydroxide

    It is used in form of chewable tablets. [5] Sucroferric oxyhydroxide is also known as a mixture of polynuclear iron(III)-oxyhydroxide, sucrose and starches. [5] The most common side effects include diarrhea and discolored feces, which may become less frequent with continued treatment. [5]

  5. Carprofen - Wikipedia

    en.wikipedia.org/wiki/Carprofen

    A 100 mg Rimadyl tablet approximately 19 mm (0.75 in) wide by 8.6 mm (0.34 in) thick, as sold in the USA. Carprofen is a nonsteroidal anti-inflammatory drug (NSAID) of the carbazole and propionic acid class that was previously for use in humans and animals but is now only available to veterinarians for prescribing as a supportive treatment for various conditions in animals. [1]

  6. Deferiprone - Wikipedia

    en.wikipedia.org/wiki/Deferiprone

    Deferiprone, sold under the brand name Ferriprox among others, is a medication that chelates iron and is used to treat iron overload in thalassaemia major. [5] It was first approved and indicated for use in treating thalassaemia major in 1994 [6] and had been licensed for use in the European Union for many years while awaiting approval in Canada and in the United States. [5]

  7. Etifoxine - Wikipedia

    en.wikipedia.org/wiki/Etifoxine

    The usual dosage of etifoxine (as the hydrochloride salt) is 150 to 200 mg per day in divided doses of 50 to 100 mg two to three times per day (e.g., 50 mg50 mg–100 mg). [ 2 ] [ 7 ] [ 6 ] [ 18 ] [ 1 ] [ 19 ] [ 20 ] It is taken for a few days to a few weeks, but no longer than 12 weeks.